An electrochemiluminescence multi-component immunoassay method based on the principle of spectral resolution
An immunoassay method and electrochemistry technology, applied in the field of electrochemiluminescence multi-component immunoassay, can solve the problems of large consumption of reagents and samples, long time consumption, and ECL analysis technology to be developed, so as to achieve less consumption of samples , small workload, good monochromatic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0075] An electrochemiluminescent multi-component immunoassay method based on the principle of spectral resolution, comprising the following steps:
[0076] (1) Preparation of three kinds of quantum dot-labeled corresponding secondary antibodies
[0077] Add 10 μL phosphate buffer solution containing 100 mg / mL 1-ethyl-3,3-dimethylaminopropylcarbodiimide and 10 μL containing 100mg / mL N-hydroxysuccinimide phosphate buffer solution, react at room temperature for 30min; after centrifugation and purification at 12000rpm, take the precipitate and add 100μL phosphate buffer solution for ultrasonic dispersion, take 15μL of the above-mentioned activated CdSe quantum dot solution and add 150 μL of 100 μg / mL carcinoembryonic antigen secondary antibody, shake at room temperature for 3 hours; then add 20 μL of 1% volume concentration of bovine serum albumin, incubate at room temperature for 1 hour, centrifuge and purify at 12000 rpm, take the precipitate and add 100 μL of phosphate buffer ...
Embodiment 2
[0088] A multi-component immunoassay method based on electrochemiluminescence, the steps are the same as in Example 1, except that:
[0089] Carcinoembryonic antigen, prostate specific antigen, and alpha-fetoprotein antigen were replaced by carbohydrate antigen 125, carbohydrate antigen 15-3, and carbohydrate antigen 72-4, respectively.
Embodiment 3
[0091] A multi-component immunoassay method based on electrochemiluminescence, the steps are the same as in Example 1, except that:
[0092] Carcinoembryonic antigen, prostate specific antigen, and alpha-fetoprotein antigen were replaced by carbohydrate antigen 19-9, free prostate specific antigen, and AIDS antigen, respectively.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com